Central DuPage Hospital - About CDH - Newsroom - Press Releases - Press Releases Archive - 2006 - CDH Logs Another U.S. First in Stroke Care
Central DuPage Hospital Logo

Ortho Award

Text Size Default Text Size button Medium Text Size button Large Text Size button
Share | Facebook Twitter YouTube
2006: CDH Logs Another U.S. First in Stroke Care
<< Back to 2006

CDH Logs Another U.S. First in Stroke Care

Winfield, Ill., January 16, 2006 -- A 45-year-old stroke patient from Geneva, Illinois went home from Central DuPage Hospital’s Neurosciences Institute this week with a newly approved stent device designed to prevent a recurrence of stroke. Central DuPage Hospital is the first community hospital in the US, and one of only two hospitals in Illinois, to have access to this important advancement in stroke prevention.

“Prevention is always the best medicine, and we finally have a tool specifically designed to open the fragile brain vessels and prevent recurrence of stroke,” said Harish Shownkeen, MD, interventional neuroradiologist and director of endovascular surgical neuroradiology at Central DuPage Hospital. “With a greater than 80 percent blockage in a brain artery from a stroke suffered in the fall, this young man was at significant risk for recurrence of a stroke. Fortunately for him, Central DuPage Hospital is part of an elite group of hospitals in the country trained on this device and we were able to offer him a promising, minimally invasive option.”

After a 24-hour stay in the hospital for implantation of the stent, the Geneva patient returned home and has returned to normal activities at his factory job.

Every year, 60,000 Americans suffer a stroke due to blocked arteries in the brain. A condition, called Intracranial Atherosclerotic Disease (ICAD), describes the plaque build up in brain vessels. Aside from medical management protocol using blood thinners such as Coumadin, Plaxis or aspirin, there was little hospitals could do to manage plaque build up in brain arteries. Unfortunately, medical management does not work for 22.5 percent of stroke patients, according to National Institute of Health studies. The use of the new Wingspan stent provides stroke patients with far better odds, reducing the chance of a recurrent stroke to just seven percent.

FDA-approved in August, only 24 of the country’s most advanced stroke centers in the U.S. have the capabilities and approval to use this stent for stroke care and prevention. These include the Cleveland Clinic, Froedtert Hospital in Milwaukee, Stanford University, Cornell University and Duke University hospitals. In Illinois, Rush University Medical Center is the only other hospital using the device. To date, the Wingspan stent has been used in almost 90 patients.

“This is a significant first in stroke treatment,” stated neurologist Henry Echiverri, M.D., who is director of the recently established Stroke Program at Central DuPage Hospital. “It is the first stent evaluated and approved by the FDA for therapy of ICAD and we are the first community hospital in the United States to treat patients with this device.”

Stents used to open cardiovascular vessels were often too rigid for the narrow twists and turns of the brain’s blood vessels. An intracranial device, the Wingspan brain stent, engineered by Boston Scientific (www.bostonscientific.com) is made of a more flexible and elastic metal than the cardiac stents. The stent has a self-expanding design, which allows it to keep the artery walls open even in curved areas of the vessel. In a minimally invasive procedure performed in an endovascular surgical neuroradiology lab, the stent is deployed using a fine catheter inserted from the femoral artery and guided through the vascular system to the blockage using advanced x-ray capabilities.

Use of the Wingspan device represents another advance for Central DuPage Hospital’s Neurosciences Institute. Last November, Dr. Shownkeen was the first physician in the U.S. (Stage III clinical trial) to use the NeuroFlo device on a stroke patient in an effort to redirect blood flow around a clot to the damaged left brain region.

“Today, we are where cardiology was 15 or 20 years ago,” explained Dr. Shownkeen. “There is new hope for stroke victims with a variety of clinical trials and new devices for both treatment and prevention.”

About the Neurosciences Institute
The Neurosciences Institute of CDH is extensive, encompassing treatment for spinal conditions, brain tumors and injury, stroke, movement and memory disorders as well as specialized programs for treatment of sleep disorders and pain. CDH was first in the region to develop a comprehensive program to treat stroke victims in the emergency room with t-PA, has a dedicated patient care unit for neurological patients served by neurological-certified nurses and a bi-plane angiography suite with 3D angiogram capabilities specifically designed for interventional neuroradiology procedures. In 2006, Central DuPage Hospital was recognized for excellence in stroke specialty by HealthGrades, a leading health care ratings organization.

About CDH
Central DuPage Hospital is a nationally recognized 361-bed facility located in Winfield, Illinois, a suburb of Chicago. The hospital is a leading center for surgical innovations and was one of the first institutions in the nation to offer minimally invasive heart surgery, as well as a new procedure for back surgeries that uses bio-engineered bone protein. In 2005, Central DuPage Hospital was named one of the Top 100 Cardiovascular Hospitals by Solucient, a nationally respected resource for evaluating health care performance.